Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-19T10:22:07.544Z Has data issue: false hasContentIssue false

10040 Proactive and responsive COVID-19 multidisciplinary research support through the University of Minnesota’s Clinical Research Support Center

Published online by Cambridge University Press:  30 March 2021

Brian L. Odlaug
Affiliation:
Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
Francoise Crevel
Affiliation:
Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
Nicole Tosun
Affiliation:
Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
Ryan Lee
Affiliation:
Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
Carrie McKenzie
Affiliation:
Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
Melena Bellin
Affiliation:
Department of Pediatrics and Surgery, University of Minnesota Medical Center, Minneapolis, MN, USA
Brenda Prich
Affiliation:
Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
Daniel Weisdorf
Affiliation:
Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

ABSTRACT IMPACT: In a global pandemic where data development and dissemination are integral to combating the disease, the Clinical Research Support Center at the University of Minnesota provides a model of comprehensive virtual support, helping to attain and disseminate novel research on COVID-19, its individual and community impact, and treatment initiatives/outcomes. OBJECTIVES/GOALS: The pandemic created massive disruption to the conduct of clinical research with an unprecedented reorientation towards COVID-19. In this fast-paced environment, the Clinical Research Support Center (CRSC) rapidly developed innovative means of supporting diverse research initiatives. METHODS/STUDY POPULATION: The CRSC rapidly transitioned into a virtual environment and developed tools for the clinical research community to enhance remote clinical trial start up. This includes supporting remote consent, eBinders, COVID-19 research training for clinical staff, and easier identification of potential participants for COVID-19 studies; all through virtual support. Support provided research teams guidance on study protocols, regulatory requirements, informatics, biostatistics, financial management, recruitment strategies to support critical, urgent COVID-19 research. We outline proactive examples of how the CRSC now provides support to research teams through the pandemic. RESULTS/ANTICIPATED RESULTS: From March-November 2020, 116 COVID-19 projects received virtual support from the CRSC for COVID-19 research: disease understanding (n=27), treatment (n=23), pandemic impact (n=20), clinical care innovation (n=18), disease control and surveillance (n=10), prevention (n=9), detection (n=5), and impact on minorities (n=4). The diversity of these studies demonstrates the demand for and benefit from multidisciplinary expertise supporting study design and implementation. Through successful articulation and acceleration of research activities, the CRSC met the need for speed and rapidly adapted to new challenges created by the pandemic. DISCUSSION/SIGNIFICANCE OF FINDINGS: In a global pandemic where rapidly changing barriers to research is ongoing, through multidisciplinary efforts, the CRSC continues to provide comprehensive, virtual support to attain and disseminate novel research on COVID-19, its individual and community impact, and treatment initiatives/outcomes.

Type
Team Science
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Association for Clinical and Translational Science 2021